Dr. Michel Chrétien's team at the Clinical Research Insitute of Montreal began clinical trials in China for an antiviral drug developed by Chrétien and his colleagues in the wake of SARS. He gives us an inside look at the lab teams fighting to find a drug that can stop COVID-19 in its tracks.
.jpg?crop=1.777xh:h;*,*&downsize=510px:*)
